PAX5 interacts with RIP2 to promote NF-κB activation and drug-resistance in B-lymphoproliferative disorders.
Wang D, Chen J, Li R, Wu G, Sun Z, Wang Z, Zhai Z, Fang F, Guo Y, Zhong Y, Jiang M, Xu H, Chen M, Shen G, Sun J, Yan B, Yu C, Tian Z, Xiao W.
Wang D, et al.
J Cell Sci. 2016 Jun 1;129(11):2261-72. doi: 10.1242/jcs.183889. Epub 2016 Apr 27.
J Cell Sci. 2016.
PMID: 27122187